These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31749638)

  • 21. Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis.
    Hudry C; Lebrun A; Moura B; Zinovieva E; Backers O; Herman-Demars H
    Rheumatol Ther; 2017 Jun; 4(1):183-194. PubMed ID: 28243967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs.
    Andre AD; Brand-Schieber E; Ramirez M; Munjal S; Kumar R
    Patient Prefer Adherence; 2017; 11():121-129. PubMed ID: 28176899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration.
    Arora S; Moclair B; Murphy K; Jaffe JS; Kaminetsky JC
    J Sex Med; 2018 Dec; 15(12):1707-1715. PubMed ID: 30393104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali
    Thakur K; Biberger A; Handrich A; Rezk MF
    Rheumatol Ther; 2016 Dec; 3(2):365. PubMed ID: 27747586
    [No Abstract]   [Full Text] [Related]  

  • 25. Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience.
    Callis Duffin K; Bukhalo M; Bobonich MA; Shrom D; Zhao F; Kershner JR; Gill A; Pangallo B; Shuler CL; Bagel J
    Med Devices (Auckl); 2016; 9():361-369. PubMed ID: 27785115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.
    Wray S; Hayward B; Dangond F; Singer B
    Expert Opin Drug Deliv; 2018 Feb; 15(2):127-135. PubMed ID: 29206056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quality characteristics and nonclinical/clinical profiles of Etanercept BS SC [MA]].
    Kyono H; Haraguchi K; Kojima S; Ota T; Jung C; Mo Yang S; Park S; So J; Kim S; Kwon J; Ko S; Yun M
    Nihon Yakurigaku Zasshi; 2018; 151(6):261-272. PubMed ID: 29887576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. User-Centric Approach to Specifying Technical Attributes of Drug Delivery Devices: Empirical Study of Autoinjector-Cap Removal Forces.
    Schneider A; Richard P; Mueller P; Jordi C; Yovanoff M; Lange J
    Patient Prefer Adherence; 2021; 15():159-168. PubMed ID: 33564226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis.
    Singer B; Wray S; Miller T; Cascione M; Gupta A; Pardo G; Watsky E; Hayward B; Mercer B; Dangond F
    Mult Scler Relat Disord; 2012 Apr; 1(2):87-94. PubMed ID: 25876936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics of HD203, a biosimilar of etanercept, with marketed etanercept (Enbrel®): a double-blind, single-dose, crossover study in healthy volunteers.
    Yi S; Kim SE; Park MK; Yoon SH; Cho JY; Lim KS; Shin SG; Jang IJ; Yu KS
    BioDrugs; 2012 Jun; 26(3):177-84. PubMed ID: 22515513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™).
    Ziemssen T; Sylvester L; Rametta M; Ross AP
    Neurol Ther; 2015 Dec; 4(2):125-36. PubMed ID: 26662362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticytokine Treatment of Rheumatoid Arthritis: An Observational Report.
    Lorkowski J; Mętrak R; Jasiewicz B
    Adv Exp Med Biol; 2022; 1374():113-119. PubMed ID: 34787830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etanercept (Enbrel
    Shannon E; Daffy J; Jones H; Paulson A; Vicik SM
    Clin Pharmacol; 2017; 9():87-99. PubMed ID: 28790869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoinjectors for administration of interferon beta-1b in multiple sclerosis: patient preferences and the ExtaviPro™ 30G and Betacomfort
    Thakur K; Manuel L; Tomlinson M
    Pragmat Obs Res; 2013; 4():19-26. PubMed ID: 27774021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etanercept Immunex.
    Yung RL
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male Subjects.
    Lee H; Chung H; Lee S; Lee H; Yang SM; Yoon SH; Cho JY; Jang IJ; Yu KS
    BioDrugs; 2017 Aug; 31(4):349-355. PubMed ID: 28551775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
    Barone DA; Singer BA; Merkov L; Rametta M; Suarez G
    Neurol Ther; 2016 Dec; 5(2):155-167. PubMed ID: 27277705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.
    Sauer M; Abbotts C
    Patient Prefer Adherence; 2018; 12():27-34. PubMed ID: 29343946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
    Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
    Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M
    J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.